Spoken Alpha · Executive

John D Cox

CEO & PresidentDYNDyne Therapeutics, Inc.

Current

Tracked since Mar 25, 2024

Tracked across 1 earnings call in our data since 2026.

Role timeline

DYNDyne Therapeutics, Inc.
Current
CEO & President
Mar 25, 2024 – Present · source: edgar_form4
DYNDyne Therapeutics, Inc.
See Remarks
Mar 25, 2024 – Mar 25, 2024 · source: edgar_form4
BIIBBIOGEN INC.
EVP Pharmaceutical Oper & Tech
Feb 8, 2015 – Apr 1, 2016 · source: edgar_form4

Research tier

See how this executive's language deviates from their own baseline

Sign in to view the per-call Behavioral Lean, the language-deviation timeline, and the novel forward-guidance phrases flagged across this executive's earnings calls — each scored against their own prior-call history.

Sign in to view Request research access

Call appearances in our data

1 call

SUPNQ4 FY2025Feb 25, 2026

SUPERNUS PHARMACEUTICALS, INC.